Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin b12 use in the vita cohort

Journal of Nutrition, Health and Aging

Volumn 16, Issue 8, 2012, Pages 687-694

  Blasko, I ^a   HInterBerger, M ^b   Kemmler, G ^a   JungwIrtH, S ^b   Krampla, W ^c   Leitha, T ^c   HeInz Tragl, K ^b   FIscHer, P ^b,c  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c DANUBE HOSPITAL   (Austria)

Author keywords

Dementia; Folic acid; Homocysteine; Mild cognitive impairment; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE;

AGED; ARTICLE; BRAIN; BRAIN ATROPHY; COGNITION; COHORT ANALYSIS; COMMUNITY CARE; DEMENTIA; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MORPHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SELF REPORT; SEX DIFFERENCE; TREATMENT OUTCOME; VIET NAM; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 85027941531     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-012-0051-y     Document Type: Article

References (44)

1. Sachdev PS. Homocysteine and brain atrophy. Prog neuropsychopharmacol Biol psychiatry. 2005 sep;29:1152-61. (Pubitemid 41383514)
2. Selhub J, Bagley LC, Miller J, Rosenberg IH. B vitamins, homocysteine, and neurocognitive function in the elderly. Am J clin nutr. 2000 Feb;71:614s-20s. (Pubitemid 30061246)
3. Weir DG, Scott JM. Brain function in the elderly: role of vitamin B12 and folate. Br Med Bull. 1999;55:669-82.
4. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA. 1983 Jun 3;249:2917-21. (Pubitemid 13096141)
5. Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed alzheimer disease. Arch neurol. 1998 nov;55:1449-55. (Pubitemid 28525506)
6. Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food nutr Bull. 2008 Jun;29:s143-s172.
7. Dangour AD, Whitehouse PJ, Rafferty K, Mitchell SA, Smith L, Hawkesworth S, Vellas B. B-vitamins and fatty acids in the prevention and treatment of alzheimer's disease and dementia: a systematic review. J alzheimers Dis. 2010;22:205-24.
8. Malouf R, Grimley EJ. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database syst rev. 2008;cD004514.
9. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. Plos one. 2010;5:e12244.
10. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J geriatr psychiatry. 2011 Jul 21.
11. Blasko I, Jellinger K, Kemmler G, Krampla W, Jungwirth S, Wichart I, Tragl KH, Fischer P. Conversion from cognitive health to mild cognitive impairment and alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine. Neurobiol aging. 2008 Jan;29:1-11. (Pubitemid 350102708)
12. Fischer P, Jungwirth S, Krampla W, Weissgram S, Kirchmeyr W, Schreiber W, Huber K, Rainer M, Bauer P, Tragl KH. Vienna transdanube aging "VIta": study design, recruitment strategies and level of participation. J Neural transm suppl. 2002;105-16. (Pubitemid 37046658)
13. Fischer P, Jungwirth S, Zehetmayer S, Weissgram S, Hoenigschnabl S, Gelpi E, Krampla W, Tragl KH. Conversion from subtypes of mild cognitive impairment to alzheimer dementia. Neurology. 2007 Jan 23;68:288-91. (Pubitemid 46148341)
14. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Backman L, Albert M, et al. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International working group on Mild cognitive Impairment. J Intern Med. 2004 sep;256:240-6. (Pubitemid 39222993)
15. Jungwirth S, Weissgram S, Zehetmayer S, Tragl KH, Fischer P. VIta: subtypes of mild cognitive impairment in a community-based cohort at the age of 75 years. Int J geriatr psychiatry. 2005 May;20:452-8. (Pubitemid 40716338)
16. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The consortium to establish a registry for alzheimer's Disease (ceraD). Part I. Clinical and neuropsychological assessment of alzheimer's disease. Neurology. 1989;39:1159-65. (Pubitemid 19239715)
17. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB. Normal ranges of neuropsychological tests for the diagnosis of alzheimer's disease. Stud Health technol Inform. 2000;77:195-9.
18. Reitan RM. Validity of the trail Making test as an indicator of organic brain damage. Perceptual and Motor skills. 1958;8:271-6.
19. Mckhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of alzheimer's disease: report of the nIncDs-aDrDa work group under the auspices of Department of Health and Human services task Force on alzheimer's Disease. Neurology. 1984 Jul;34:939-44. (Pubitemid 14076461)
20. Clinical and neuropathological criteria for frontotemporal dementia. The lund and Manchester groups. J neurol neurosurg psychiatry. 1994 apr;57:416-8.
21. Mckeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with lewy bodies (DlB): report of the consortium on DlB International workshop. J alzheimers Dis. 2006;9:417-23. (Pubitemid 44253336)
22. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, et al. Vascular dementia: diagnostic criteria for research studies. Report of the nInDs-aIren International workshop. Neurology. 1993 Feb;43:250-60. (Pubitemid 23060253)
23. Fischer P, Krampla W, Mostafaie N, Zehetmayer S, Rainer M, Jungwirth S, Huber K, Bauer K, Hruby W, et al. VIta study: white matter hyperintensities of vascular and degenerative origin in the elderly. J neural transm suppl. 2007;181-8.
24. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. Mr signal abnormalities at 1.5 t in alzheimer's dementia and normal aging. AJr am J roentgenol. 1987 aug;149:351-6. (Pubitemid 17104996)
25. Scheltens P, Barkhof F, Leys D, Pruvo JP, Nauta JJ, Vermersch P, Steinling M, Valk J. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J neurol sci. 1993 Jan;114:7-12. (Pubitemid 23025201)
26. Bracco L, Piccini C, Manfredi G, Fonda C, Falcini M, Amaducci L. Magnetic resonance measures in alzheimer disease: their utility in early diagnosis and evaluating disease progression. Alzheimer Dis assoc Disord. 1999 Jul;13:157-64.
27. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in alzheimer's disease. Lancet. 1996 Jul 13;348:94-7. (Pubitemid 26234357)
28. Luxenberg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the alzheimer type correlates with rate of neuropsychological deterioration. Neurology. 1987 Jul;37:1135-40. (Pubitemid 17123443)
29. Meese W, Kluge W, Grumme T, Hopfenmuller W. CT evaluation of the csF spaces of healthy persons. Neuroradiology. 1980 apr;19:131-6. (Pubitemid 10098077)
30. Huber KR, Mostafaie N, Stangl G, Worofka B, Kittl E, Hofmann J, Hejtman M, Michael R, Weissgram S, et al. Clinical chemistry reference values for 75-year-old apparently healthy persons. Clin chem lab Med. 2006;44:1355-60. (Pubitemid 44706715)
31. Mitchell AJ, Shiri-Feshki M. Rate of progression of mild cognitive impairment to dementia-meta-analysis of 41 robust inception cohort studies. Acta psychiatr scand. 2009 apr;119:252-65.
32. Ganguli M, Snitz BE, Saxton JA, Chang CC, Lee CW, Vander BJ, Hughes TF, Loewenstein DA, Unverzagt FW, petersen RC. Outcomes of mild cognitive impairment by definition: a population study. Arch neurol. 2011 Jun;68:761-7.
33. Manly JJ, Tang MX, Schupf N, Stern Y, Vonsattel JP, Mayeux R. Frequency and course of mild cognitive impairment in a multiethnic community. Ann neurol. 2008 apr;63:494-506. (Pubitemid 351614715)
34. Annerbo S, Wahlund LO, Lokk J. The relation between homocysteine levels and development of alzheimer's disease in mild cognitive impairment patients. Dement geriatr cogn Disord. 2005;20:209-14. (Pubitemid 41291571)
35. Luchsinger JA, Tang MX, Miller J, Green R, Mayeux R. Relation of higher folate intake to lower risk of alzheimer disease in the elderly. Arch neurol. 2007 Jan;64:86-92. (Pubitemid 46072428)
36. Brown B, Huang MH, Karlamangla A, Seeman T, kado D. Do the effects of apoe-epsilon4 on cognitive function and decline depend upon vitamin status? Macarthur studies of successful aging. J nutr Health aging. 2011 Mar;15:196-201.
37. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U. Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin chem lab Med. 2005;43:1096-100. (Pubitemid 41581967)
38. Vogiatzoglou A, Refsum H, Johnston C, Smith SM, Bradley KM, De JC, Budge MM, Smith AD. Vitamin B12 status and rate of brain volume loss in community-dwelling elderly. Neurology. 2008 sep 9;71:826-32.
39. Seshadri S, Wolf PA, Beiser AS, Selhub J, Au R, Jacques PF, Yoshita M, Rosenberg IH, D'agostino RB, Decarli C. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham offspring study. Arch neurol. 2008 May;65:642-9. (Pubitemid 351679660)
40. Sachdev PS, Parslow R, Wen W, Anstey KJ, Easteal S. Sex differences in the causes and consequences of white matter hyperintensities. Neurobiol aging. 2009 Jun;30:946-56.
41. De lau LM, Smith AD, Refsum H, Johnston C, Breteler MM. Plasma vitamin B12 status and cerebral white-matter lesions. J neurol neurosurg psychiatry. 2009 Feb;80:149-57.
42. Bradburn NM, Rips LJ, Shevell SK. Answering autobiographical questions: the impact of memory and inference on surveys. Science. 1987 apr 10;236:157-61.
43. Chan A, Remington R, Kotyla E, Lepore A, Zemianek J, Shea TB. A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia. J nutr Health aging. 2010 Mar;14:224-30.
44. Mooijaart SP, Gussekloo J, Frolich M, Jolles J, Stott DJ, Westendorp RG, De Craen AJ. Homocysteine, vitamin B-12, and folic acid and the risk of cognitive decline in old age: the leiden 85-plus study. Am J clin nutr. 2005 oct;82:866-71. (Pubitemid 43779702)